OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients
Massimo Franchini, Daniele Focosi, Elena Percivalle, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1443-1443
Open Access | Times Cited: 11
Massimo Franchini, Daniele Focosi, Elena Percivalle, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1443-1443
Open Access | Times Cited: 11
Showing 11 citing articles:
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2250647-e2250647
Open Access | Times Cited: 125
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2250647-e2250647
Open Access | Times Cited: 125
Single Monoclonal Antibodies Should Not Be Used for Coronavirus Disease 2019 Therapy: A Call for Antiviral Stewardship
Arturo Casadevall, Daniele Focosi, Liise-anne Pirofski, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 6, pp. 1404-1407
Closed Access | Times Cited: 4
Arturo Casadevall, Daniele Focosi, Liise-anne Pirofski, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 6, pp. 1404-1407
Closed Access | Times Cited: 4
Double-blinded, randomised, placebo-controlled trial of convalescent plasma for COVID-19: analyses by neutralising antibodies homologous to recipients’ variants
Tuba Khawaja, Mikael Kajova, Iris Levonen, et al.
Infectious Diseases (2024) Vol. 56, Iss. 6, pp. 423-433
Open Access | Times Cited: 3
Tuba Khawaja, Mikael Kajova, Iris Levonen, et al.
Infectious Diseases (2024) Vol. 56, Iss. 6, pp. 423-433
Open Access | Times Cited: 3
WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
Massimo Franchini, Arturo Casadevall, Michael J. Joyner, et al.
Life (2023) Vol. 13, Iss. 1, pp. 134-134
Open Access | Times Cited: 9
Massimo Franchini, Arturo Casadevall, Michael J. Joyner, et al.
Life (2023) Vol. 13, Iss. 1, pp. 134-134
Open Access | Times Cited: 9
Effectiveness of COVID-19 Convalescent Plasma (CCP) During the Pandemic Era: A Literature Review
Usha Rani Kandula, Techane Sisay Tuji, Dinkinesh Begna Gudeta, et al.
Journal of Blood Medicine (2023) Vol. Volume 14, pp. 159-187
Open Access | Times Cited: 7
Usha Rani Kandula, Techane Sisay Tuji, Dinkinesh Begna Gudeta, et al.
Journal of Blood Medicine (2023) Vol. Volume 14, pp. 159-187
Open Access | Times Cited: 7
COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
High‐titer post‐vaccine COVID‐19 convalescent plasma for immunocompromised patients during the first omicron surge
Ralph Tayyar, Lisa Wong, Alex Dahlen, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. 2
Open Access | Times Cited: 3
Ralph Tayyar, Lisa Wong, Alex Dahlen, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. 2
Open Access | Times Cited: 3
Towards the identification of the correct place for convalescent plasma among COVID-19 therapies
Massimo Franchini, Daniele Focosi
Infectious Diseases (2024) Vol. 56, Iss. 6, pp. 421-422
Open Access
Massimo Franchini, Daniele Focosi
Infectious Diseases (2024) Vol. 56, Iss. 6, pp. 421-422
Open Access
THE POTENTIAL OF HUMAN PLASMA AND HUMAN BLOOD PRODUCTS FOR IMMUNE PROTECTION
Vancho Donev, Georgi Nikolov
PROBLEMS of Infectious and Parasitic Diseases (2024) Vol. 52, Iss. 1, pp. 22-28
Open Access
Vancho Donev, Georgi Nikolov
PROBLEMS of Infectious and Parasitic Diseases (2024) Vol. 52, Iss. 1, pp. 22-28
Open Access
Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS‐CoV‐2 Variants: A Case Report Study with Comparison to a Vaccinated Population
Constant Gillot, Jean‐Louis Bayart, Vincent Maloteau, et al.
Case Reports in Infectious Diseases (2024) Vol. 2024, Iss. 1
Open Access
Constant Gillot, Jean‐Louis Bayart, Vincent Maloteau, et al.
Case Reports in Infectious Diseases (2024) Vol. 2024, Iss. 1
Open Access
Evaluation of neutralizing capacity of tixagevimab plus cilgavimab: a case-series study with comparison to a vaccinated population
Constant Gillot, Jean‐Louis Bayart, Vincent Maloteau, et al.
Research Square (Research Square) (2023)
Open Access
Constant Gillot, Jean‐Louis Bayart, Vincent Maloteau, et al.
Research Square (Research Square) (2023)
Open Access
